Document is current
Any future updates will be listed below
-
Authors
Wang, Hanzhi
Rajagopal, Athulram
Cao, Ke
Cimolai, Kristen
Petchiny, Tera N.
White, Stephanie D.
Cheung, Justin
Loblaw, Andrew
Vesprini, Danny
Leong, Hon
Escueta, Vivette
Zhang, Liying
Glicksman, Rachel
Cheung, Patrick
Wang, Chao
Liu, Stanley K.
-
Funding
Funding for this research was provided by:
Canadian Institutes of Health Research (PJT-162384)
Ontario Graduate Scholarship
SCACE Fellowship in Prostate Cancer Research
Queen Elizabeth II/Sunnybrook and Women’s College Health Sciences Centre Graduate Scholarships in Science and Technology
MBP Caven and Lockwood-Graham Scholarship
AbbVie Canada
Canadian Cancer Society (#708133)
Ride for Dad and the Prostate Cancer Fight Foundation
Prostate Cancer Canada Movember Rising Star (RS2014-03)
Sunnybrook Foundation
- License Information
-
More Information
Article History
Received: 4 December 2025
Accepted: 10 March 2026
First Online: 26 March 2026
Declarations
:
: The study (iSTOP, Clinical Trial ID: NCT04619069; Date of Registration: 6/11/2020) was approved by the Sunnybrook research ethics board (REB #: 2321) and written, informed consent was obtained from all participants. All methods were performed in accordance with the relevant guidelines and regulations. All study protocols adhered to the principles of the Declaration of Helsinki.
: Not applicable. No identifiable details relating to an individual person are present in this manuscript.
: The authors would like to acknowledge funding from AbbVie Canada for the iSTOP trial. The authors declare no additional conflicts of interest.
